36F79720D0180 36C25526N0394_1.docx

DOCX document 19 KB Posted

Attached to
6505--ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063
Solicitation number
36C25526N0394
Issued by

About this file

This is an Award Notice for a Federal Supply Schedule (FSS) order issued by the Department of Veterans Affairs Network Contracting Office (NCO 15) in Leavenworth, Kansas. The award was made to Novartis Pharmaceuticals Corporation (UEI: NG61ZA8TADW3) on August 5, 2026, for the supply of PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), a proprietary radiopharmaceutical agent indicated for adult patients with PSMA-positive metastatic castration-resistant prostate cancer who have received prior androgen receptor pathway inhibition and taxane-based chemotherapy. The total award amount is $891,650.76 for 26 units at a unit price of $34,294.26, with delivery and performance at VA St. Louis Health Care System John J. Cochran Veterans Hospital in St. Louis, Missouri.

The ordering period runs from August 5, 2026, through February 5, 2027, under FSS Contract 36F79720D0180 and Order Number 36C25526N0394. The contractor's primary point of contact is Yisell Rodriguez (yisell.rodriquez@novartis.com). Monthly invoices in arrears must reference PO number 657-C60305 and be submitted electronically through the VA Financial Services Center e-invoicing system. The Contracting Officer is Michael P. Murphy (michael.murphy7@va.gov), and the Facility Point of Contact is Mark Lauridsen at VA St. Louis Health Care System. The contract is subject to VA regulations including provisions for delivery location, electronic payment submission, and quality assurance procedures as outlined in the Statement of Work included in the SF 1449.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Award Notice

SUBJECT*
ME/ New Pluvicto Theronastic Therapy Radiopharmaceuticals/STL(VA-26-00053903) 657-26-4-1642-0063

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*
66048
SOLICITATION NUMBER*
36C25526N0394

BASE NOTICE TYPE

ARCHIVE
60 DAYS AFTER THE AWARD DATE
RECOVERY ACT FUNDS
N
PRODUCT SERVICE CODE*
6505
NAICS CODE*
325412

SET-ASIDE

CONTRACTING OFFICE ADDRESS
Department of Veterans Affairs

Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway

Leavenworth KS 66048

POINT OF CONTACT*

Michael Murphy michael.murphy7@va.gov

AWARD INFORMATION

AWARD NUMBER*
36F79720D0180 36C25526N0394
AWARD AMOUNT*
891,650.00

LINE ITEM NUMBER

AWARD DATE (MM-DD-YYYY)*
08-05-2026
AWARDEE NAME*
NOVARTIS PHARMACEUTICALS CORPORATION
CONTRACTOR’S UEI
NG61ZA8TADW3

AWARDEE ADDRESS LINE 1*

AWARDEE ADDRESS LINE 2*

AWARDEE ADDRESS LINE 3*
59 ROUTE 10

AWARDEE ADDRESS LINE 4*

AWARDEE CITY
EAST HANOVER
AWARDEE STATE
NJ
AWARDEE ZIP CODE
07936

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS
michael.murphy7@va.gov

EMAIL DESCRIPTION

DESCRIPTION

1. Ordering Activity / Contracting Office Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway Leavenworth, KS 66048

2. Contract / Order Information

· FSS Contract Number: 36F79720D0180

· Order Number: 36C25526N0394

· Requisition / PO Number: 657-C60305

· Effective Date of Award: August 5, 2026Ordering Period: August 5, 2026 through February 5, 2027

· Method of Solicitation: FSS order under SF 1449, commercial products and commercial services

3. Awardee (Contractor) Novartis Pharmaceuticals Corporation 59 Route 10 East Hanover, NJ 07936 UEI: NG61ZA8TADW3 (as shown on the SF 1449).

Primary Contractor POC:

Yisell Rodriguez, 201‑602‑5055, yisell.rodriquez@novartis.com.

4. Place of Delivery / Performance VA St. Louis Health Care System John J. Cochran Veterans Hospital 915 North Grand Boulevard St. Louis, MO 63106

5. Description of Supplies/Services This award provides one proprietary radiopharmaceutical agent, PLUVICTO (Lutetium Lu 177 vipivotide tetraxetan), NDC 69488‑0010‑6, for use by Nuclear Medicine at VA St. Louis Health Care System.

PLUVICTO is indicated for adult patients with PSMA‑positive metastatic castration‑resistant prostate cancer who have been treated with androgen receptor pathway inhibition and taxane‑based chemotherapy.

The period of performance supports diagnostic and therapeutic use of this radiopharmaceutical in accordance with the Statement of Work included in the SF 1449.

6. Line Item and Pricing

· CLIN 0001: PLUVICTO Lutetium Lu 177 vipivotide tetraxetan, NDC 69488‑0010‑6.

· Quantity: 26 Each.

· Unit Price: 34,294.26.

· Extended Amount: 891,650.76.

· Total Award Amount: 891,650.76.

7. Funding / Accounting Data As shown on SF 1449:

657‑26‑4‑1642‑0063 / 657‑3660 / 160‑1642‑822900‑2580 / 0100L00H6 (Accounting and Appropriation Data).

8. Invoice and Payment Instructions Invoices shall be submitted monthly in arrears and must reference PO number 657‑C60305 and Order number 36C25526N0394.

All invoices shall be submitted electronically in accordance with VAAR 852.232‑72, via the VA Financial Services Center e-invoicing system (Austin, TX).

Payment will be made by: Department of Veterans Affairs Financial Services Center, Austin, TX (see SF 1449 Block 18a and Continuation Page for full details).

9. Contract Administration / Points of Contact Contracting Officer:

Michael P. Murphy Department of Veterans Affairs Network Contracting Office (NCO 15) 3450 S 4th Street Trafficway, Leavenworth, KS 66048 Email: michael.murphy7@va.gov Phone: 913‑946‑1970 Facility Point of Contact (Pluvicto):

Mark Lauridsen VA St. Louis Health Care System Email: mark.lauridsen@va.gov Phone: 314‑652‑4100 ext. 66522 The Contracting Officer retains sole authority to approve changes or modifications affecting price, quantity, or quality of performance under this contract.

The Contracting Officer’s Representative (COR) will be designated separately in accordance with VAAR 852.270‑1 and will be responsible for technical and administrative oversight.

10. Special Terms and Conditions This order is subject to the terms and conditions of FSS Contract 36F79720D0180 and all clauses incorporated by reference on SF 1449, including VAAR 852.247‑71 (Delivery Location), VAAR 852.232‑72 (Electronic Submission of Payment Requests), VAAR 852.203‑70 (Commercial Advertising), VAAR 852.242‑71 (Administrative Contracting Officer), and VAAR 852.246‑71 (Rejected Goods).

The VA St. Louis Health Care System’s business hours and applicable federal holidays are as set forth in the Statement of Work, and contract performance monitoring will be conducted in accordance with VA quality assurance procedures described therein.

*= Required Field Award Notice

File details come from the government source that posted it. Updated .